If drug donors or recipients do not consider the above key principles in the process of drug donation, these donations will not be only useless rather it will create problems in the recipient country. Firstly, if the donated drugs are not in compliance with the need of country, they will make the situation worse for pharmaceutical companies of the country (Kevin, 2009). Secondly, some donations are not considerate towards the amount of medication donated. Therefore, excessive amounts of drugs result in a backlog of specific drugs. The managers face difficulty in dealing with these excessive amounts of medications. Thirdly, the hospital never uses some types of donated medications. Their doctors have no experiences about the usage and untoward effects of the specific drugs. They cannot issue these medicines to patients so these medications are wasted. Fourthly, if the quality of drugs does not meet the standard they may adversely affect the health of patients. Moreover, if all the above criteria are being fulfilled, but the drugs have insufficient shelf life, they will still be of no use to the pharmaceutical companies, government or hospitals. They will have to discard them.
The question, here, arises that who is actually responsible for managing and observing principles of the above discussed principles of drug donations in a country. Huebner (2013) emphasizes that government has responsibility of supporting the donations of drugs, instead of pharmaceutical companies. According to the special nature of medicines, only the government can strictly control the production, distribution, storage, transport and other sectors. Hence the government should choose and buy the medications from the pharmaceutical companies. Next, send diverse types of medications to the different disaster area. The research also shows that pharmaceutical companies are business entities. They need income as other businesses to cover costs of material and production but in case they conduct donations. These should be non-profit. They have no relationship with the liability of provision of drugs in the areas which lack proper medication. It means that the manufacturers of pharmaceutical companies can choose whether they donate the medications by themselves. Therefore, the pharmaceutical companies have no responsibility to forcibly support the essential medications to the poor area and some places.